AFP
CC icon

Ausdal Financial Partners’s Chemours CC Stock Holding History

Ausdal Financial Partners’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-499
Closed -$3K – 327
2015
Q4 		$3K Buy
+499
New +$3.19K ﹤0.01% 1156

Other funds holding CC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CCM
Conatus Capital Management Greenwich, Connecticut $92.3M AUM 45.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Ausdal Financial Partners's CC Position: Q1 2016 in Review

Ausdal Financial Partners sold out of Chemours (CC) in Q1 2016, closing a stake of 499 shares — an estimated $3K sold.

Ausdal Financial Partners first reported a position in CC in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 416 funds tracked by Wall St. Rank hold CC as of Q1 2016.

  • Ausdal Financial Partners reported no remaining Chemours position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 499 Chemours shares in Q1 2016, an estimated $3K.
  • Ausdal Financial Partners first reported a position in Chemours in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's Chemours position peaked at $3K in Q4 2015.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.